a16z | Big Ideas in 2024: Programming Medicine’s Final Frontier with Jorge Conde @a16z | Uploaded December 2023 | Updated October 2024, 3 hours ago.
Traditional drug development is like single-use rockets—costly and bespoke. But, inspired by SpaceX's rocket reusability, imagine programmable medicines that reuse components, transforming the way we innovate.

General PartnerJorge Conde shares his Big Idea for 2024 and how the FDA is embracing this shift, adopting the FAA's approach to aviation safety for transparent and flexible evaluations of programmable medicines.

Timecodes:
00:00 - Big Ideas in Tech 2024
01:39 - Programming Medicine’s Final Frontier
03:07 - The three stages of developing drugs in 2023
06:35 - The impact of programmable medicine
10:48 - The FDA and office of The Office of Therapeutic Products
16:01 - What does programmable medicine unlock for business?
17:52 - Regulation, cost, and access

Resources:
View all 40+ big ideas: a16z.com/bigideas2024
Find Jorge on Twitter: twitter.com/JorgeCondeBio

Stay Updated:
Find a16z on Twitter: twitter.com/a16z
Find a16z on LinkedIn: linkedin.com/company/a16z
Subscribe on your favorite podcast app: a16z.simplecast.com
Follow our host: twitter.com/stephsmithio

Please note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any a16z fund. a16z and its affiliates may maintain investments in the companies discussed. For more details please see a16z.com/disclosure